Gerald S Post Selected Research

rabacfosadine

1/2022	Multicenter, randomized, double-blinded, placebo-controlled study of rabacfosadine in dogs with lymphoma.
3/2020	Concurrent use of rabacfosadine and L-asparaginase for relapsed or refractory multicentric lymphoma in dogs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gerald S Post Research Topics

Disease

4	Neoplasms (Cancer) 01/2022 - 11/2005
2	Lymphoma (Lymphomas) 01/2022 - 03/2020
1	Squamous Cell Carcinoma of Head and Neck 06/2017
1	Carcinoma (Carcinomatosis) 02/2011
1	Nephrogenic Diabetes Insipidus 09/2002
1	Polydipsia 09/2002
1	Polyuria 09/2002

Drug/Important Bio-Agent (IBA)

2	rabacfosadineIBA 01/2022 - 03/2020
2	toceranib phosphateIBA 01/2018 - 06/2017
2	Proteins (Proteins, Gene)FDA Link 02/2011 - 11/2005
1	fucoidanIBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2020
1	Antineoplastic Agents (Antineoplastics)IBA 03/2020
1	Asparaginase (Elspar)FDA Link 03/2020
1	Sepharose (Agarose)IBA 02/2011
1	Conditioned Culture MediaIBA 02/2011
1	Tyrosine Kinase InhibitorsIBA 11/2005
1	Imatinib Mesylate (Gleevec)FDA Link 11/2005
1	Vasopressins (Vasopressin)IBA 09/2002

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2022 - 03/2020
1	Aftercare (After-Treatment) 03/2020
1	Duration of Therapy 01/2018
1	Therapeutics 06/2017